Blood Irradiator Market - Size, Share,
Outlook, and Opportunity Analysis, 2018 –
2026
Blood irradiators are used to irradiate blood and blood components to prevent the proliferation of T
lymphocytes that can inhibit the immune response leading to graft-versus-host disease (GVHD).
The blood irradiators are widely used in various medical and research applications such as
preparing blood for transfusion and cancer research. Irradiation procedure is necessary for
transfusion recipients at risk for GVHD, including fetuses receiving intrauterine transfusions,
patients undergoing hematopoietic transplantation, and individuals receiving platelets. Blood
irradiators has applications in irradiation of blood, which is essential for surgeries, cancer treatment,
chronic illnesses, and traumatic injuries.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1972
Blood Irradiator Market Drivers
Irradiated blood is provided to prevent rare complications of transfusion called transfusion-
associated graft-versus-host disease, a rare but serious complication of blood transfusion caused by
white blood cells in the blood transfused. According to the Royal Children’s Hospital Melbourne,
transfusion- associated graft-versus-host disease (TA-GVHD) occurs when donor lymphocytes from
transfused blood engraft in the recipient, causing diseases such as hepatitis, diarrhea and
pancytopenia with clinical features of fever and skin rash and is fatal in more than 90% of cases.
Moreover, support from government organizations for development of novel irradiators to ensure
safe blood transfusions is driving market growth. For instance, in 2014, Stellarray, Inc., developer
of novel x-ray sources, was awarded the US$ 1.1 Mn grant by the Department of Energy to develop